IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of cash flow for the year ended December 31

in CHF 1 000

 

Notes

 

2021

 

2020

Cash flows from operating activities

 

 

 

 

 

 

Proceeds from sales of securities

 

4

 

926 988

 

1 008 571

Purchase of securities

 

4

 

(962 091)

 

(699 354)

Dividend receipts

 

 

 

 

243

Interest receipts

 

 

 

 

7

Payments for services

 

 

 

(59 545)

 

(46 973)

Income taxes paid

 

 

 

(139)

 

(45)

Total cash flows from operating activities

 

 

 

(94 787)

 

262 449

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

Dividend

 

 

 

(199 440)

 

(188 360)

Proceeds from sales of treasury shares

 

7

 

9 653

 

20

Purchase of treasury shares

 

7

 

(9 459)

 

(8 260)

Borrowing/(repayment) of bank loans

 

5

 

292 000

 

(87 000)

Interest payments

 

 

 

(986)

 

(883)

Total cash flows from financing activities

 

 

 

91 768

 

(284 483)

 

 

 

 

 

 

 

Foreign exchange difference

 

 

 

(962)

 

(1 857)

Change in cash and cash equivalents

 

 

 

(3 981)

 

(23 891)

 

 

 

 

 

 

 

Cash and cash equivalents at the beginning of the year

 

 

 

6 816

 

30 707

 

 

 

 

 

 

 

Cash and cash equivalents at the end of the year

 

 

 

2 835

 

6 816

The notes are an integral part of the consolidated financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer